DOCSLIB.ORG

New York State Mandatory Prescriber Education Guidance

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
New York State Mandatory Prescriber Education Guidance New York State Mandatory Prescriber Education Guidance NYSNA Continuing Education The New York State Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. The New York State Nurses Association is accredited by the International Association for Continuing Education and Training "IACET" and is authorized to issue the IACET CEU. This course has been awarded 4.0 Contact Hours and 0.4 CEUs and is intended for Nurse Practitioners and other healthcare prescribers who have a DEA registration number to prescribe controlled substances, as well as medical residents who prescribe controlled substances under a facility DEA registration number. In order to receive contact hours/CEUs, participants must read the course material, pass an examination with at least 80%, and complete an evaluation. Contact hours/CEUs will be awarded for this independent study course until March 18, 2024. In addition, prescribers must attest to their own completion of this program. The certificate of completion must be maintained by the prescriber for a minimum of six (6) years from the date of the attestation. All American Nurses Credentialing Center (ANCC) accredited organizations' contact hours are recognized by all other ANCC accredited organizations. Most states with mandatory continuing education requirements recognize the ANCC accreditation/approval system. Questions about the acceptance of ANCC contact hours to meet mandatory regulations should be directed to the Professional licensing board within that state. NYSNA has been granted provider status by the Florida State Board of Nursing as a provider of continuing education in nursing (Provider number 50-1437). NYSNA wishes to disclose that no commercial support or sponsorship has been received. NYSNA planners and presenters declare that they have no conflict of interest in this program. New York State Mandatory Prescriber Education Guidance 1 ©2021, NYSNA. All Rights Reserved. No material may be reprinted without written permission. How to Take This Course Please take a look at the steps below; these will help you to progress through the course material, complete the course examination and receive your certificate of completion. 1. REVIEW THE OBJECTIVES The objectives provide an overview of the entire course and identify what information will be focused on. Objectives are stated in terms of what you, the learner, will know or be able to do upon successful completion of the course. They let you know what you should expect to learn by taking a particular course and can help focus your study. 2. STUDY EACH SECTION IN ORDER Keep your learning "programmed" by reviewing the materials in order. This will help you understand the sections that follow. 3. COMPLETE THE COURSE EXAM After studying the course, click on the "Course Exam" option located on the course navigation toolbar. Answer each question by clicking on the button corresponding to the correct answer. All questions must be answered before the test can be graded; there is only one correct answer per question. You may refer back to the course material by minimizing the course exam window. 4. GRADE THE TEST Next, click on "Submit Test." You will know immediately whether you passed or failed. If you do not successfully complete the exam on the first attempt, you may take the exam again. If you do not pass the exam on your second attempt, you will need to purchase the course again. 5. FILL OUT THE EVALUATION FORM Upon passing the course exam you will be prompted to complete a course evaluation. You will have access to the certificate of completion after you complete the evaluation. At this point, you should print the certificate and keep it for your records. New York State Mandatory Prescriber Education Guidance 2 ©2021, NYSNA. All Rights Reserved. No material may be reprinted without written permission. Course Objectives Upon completion of this course, the learner will be able to: • Describe New York State and Federal requirements for safe prescribing controlled substances. • Recognize appropriate prescribing guidelines for opioid analgesics for acute and chronic pain. • Outline prevention, screening and signs of addiction. • Identify responses to abuse and addiction. • Discuss Palliative and End of life care. New York State Mandatory Prescriber Education Guidance 3 ©2021, NYSNA. All Rights Reserved. No material may be reprinted without written permission. Introduction Course Description: The use of prescription and non-prescription opioids has dramatically increased in New York State. Healthcare providers who prescribe opioids must understand and demonstrate ongoing knowledge in regard to the following topics: • Federal requirements for prescribing controlled substances; • New York State requirements for prescribing controlled substances; • appropriate prescribing; • managing acute pain; • palliative care; • pain management, prevention, screening and signs of addiction; • responses to abuse and addiction; and • end of life care. Purpose: The purpose of this activity is to satisfy the Public Health Law (PHL) §3309-a (3), available here: https://www.nysenate.gov/legislation/laws/PBH/3309 Target Audience: The Public Health Law mandates prescribers licensed under Title Eight of the Education Law in New York that treat humans and who have a DEA registration number to prescribe controlled substances, as well as medical residents who prescribe controlled substances under a facility DEA registration number, must complete at least three (3) hours of course work. This training will encompass: • pain management • palliative care • addiction This includes: • physicians • physician assistants • advanced practice nurses who prescribe • dentists • registered nurses • pharmacists • residents The New York State Department of Health (NYS DOH) has provided a FAQ sheet in response to potential questions a prescriber may have about the mandatory NYS Prescriber Education. To read this FAQ please visit the following web address: https://www.health.ny.gov/professionals/narcotic/mandatory_prescriber_education/docs/faq. Compliance and Attestation Provider compliance: This course must be completed by July 1, 2017 and every three (3) years thereafter. If you are licensed on or after July 1, 2017 you must complete the training with in one (1) year of receipt of your license and every three (3) years thereafter. Provider attestation: To comply, prescribers must file the self-attestation by July 1, 2017 and once every three (3) years thereafter. To submit your attestation online, access your Health Commerce System (HCS) account and follow these steps: After logging in to the HCS website (https://commerce.health.state.ny.us/public/hcs_login.html): 1. Top Right under "my content" 2. Select "ALL applications" then 3. Browse by letter "N" and the first application name is "Narcotic Education Attestation Tracking (NEAT)" New York State Mandatory Prescriber Education Guidance 4 ©2021, NYSNA. All Rights Reserved. No material may be reprinted without written permission. 4. Select "NEAT" - Follow the steps provided (https://www.nyacp.org/files/NEAT%20Prescriber%20Instructions%203_30_17.pdf) Prescribers that do not have access to a computer can request a paper attestation form by calling the Bureau of Narcotic Enforcement (BNE) toll-free at 1-866-811-7957. They may then complete the form and return it by mail to the address provided. New York State Mandatory Prescriber Education Guidance 5 ©2021, NYSNA. All Rights Reserved. No material may be reprinted without written permission. About the Author Jennifer Klimek Yingling, Ph.D, RN, ANP-BC, FNP-BC Dr. Jennifer Klimek Yingling is an Assistant Professor at Utica College. She is an upstate New York resident helping to strengthen the community through practice, academics and research. Jennifer studied at Mohawk Valley Community College, the State University of New York Institute of Technology and received her Doctorate of Philosophy in Nursing from Rutgers University. A passionate caregiver and a patient advocate, she is dual boarded Family and Adult Nurse Practitioner. Her more than two decades of nursing experience include experience in medical surgical, emergency, forensic, occupational and student health. Dr. Klimek Yingling currently practices clinically weekly which brings real life experiences to the classroom. Her research activities include work with breast cancer survivorship, evidence-based practice, horizontal violence, emergency department throughput and Adverse Childhood Experiences. New York State Mandatory Prescriber Education Guidance 6 ©2021, NYSNA. All Rights Reserved. No material may be reprinted without written permission. Pain The International Association for the Study of Pain (IASP, 2020) revised the definition of pain as: "An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage" IASP (2020) also added the following statements to further define pain: "Pain is always a personal experience that is influenced to varying degrees by biological, psychological, and social factors; Pain and nociception are different phenomena; Pain cannot be inferred solely from activity in sensory neurons; Through their life experiences, individuals learn the concept of pain; A person's report of an experience as pain should be respected; Although pain usually serves an adaptive role, it may have adverse effects on function and social and psychological
Load more

Recommended publications
  • Studies of Somatosensory and Pain Neural Circuits with High Field
    STUDIES OF SOMATOSENSORY AND PAIN NEURAL CIRCUITS WITH HIGH FIELD FUNCTIONAL MRI By Elizabeth Ann Stringer Dissertation Submitted to the Faculty of the Graduate School of Vanderbilt University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in Neuroscience December, 2010 Nashville, Tennessee Approved: Professor Stephen Bruehl Professor Li Min Chen Professor John C. Gore Professor Jon Kaas Professor Ronald Wiley For my grandfather, John Charles Katz ii ACKNOWLEDGMENTS This research would not have been possible without the financial support of the National Institutes of Health through grants awarded to my advisor, Dr. John C. Gore. Most significantly the EB000461 grant has supported my research on the 7-T MR scanner for the last three years, and the T32 EB003817 predoctoral training grant supported two years of my research. I must acknowledge and thank my advisor Dr. Gore for taking a chance on me when I was a first year graduate student. He provided the finances that allowed me to acquire data whenever I needed to, procure new equipment, travel to conferences, and the list goes on. My research could not have been accomplished without the Vanderbilt University Institute of Imaging Science’s (VUIIS) 7-T scanner and the group of interdisciplinary scientists that keep it operational for human research. None of this would have been possible without Dr. Gore’s vision. I thank my committee members for encouraging me in my research. Their genuine interest in my projects has served as wonderful motivation. Dr. Li Min Chen has been a co-advisor to me and has taught me a great deal about sensory systems and manuscript writing, and her guidance has been critical to my development as a scientist.
    [Show full text]
  • Brown Medical School Biomed 370 the Brain and Human Behavior
    Brown Medical School Biomed 370 The Brain and Human Behavior The Brain and Human Behavior Biomed 370 A first year, second semester course sponsored by the Department of Psychiatry and Human Behavior Course Directors: Robert Boland, M.D. 455-6417 (office), 455-6497 (fax) [email protected] Stephen Salloway, M.D., M.S. 455-6403 (office), 455-6405 (fax) [email protected] Web site available through WebCT Teaching Assistants: Nancy Brim ([email protected]) Marisa Kastoff ([email protected]) Stan Pelosi ([email protected]) Grace Farris ([email protected]) Table of Contents. Overall Course Objectives.....................................................................4 Section 1. Basic Principles. ...................................................................7 Chapter 1. Limbic System Anatomy........................................................8 Chapter 2. Frontal Lobe Function And Dysfunction..............................13 Chapter 3. Clinical Neurochemistry......................................................19 Chapter 4. The Neurobiology Of Memory............................................36 Chapter 5. The Control Of Feeding Behavior .......................................46 Chapter 6. Principles Of Pharmacology................................................51 Chapter 7. Principles Of Neuroimaging.................................................55 Chapter 8. The Mental Status Examination...........................................74 Section 2. The Clinical Disorders.......................................................89
    [Show full text]
  • Sensory and Immune Changes in Zoster-Affected Dermatomes: a Review*
    Included in the theme issue: INFLAMMATORY SKIN DISEASES Acta Derm Venereol 2012; 92: 378–382 Acta Derm Venereol 2012; 92: 339–409 MINI-REVIEW Beyond Zoster: Sensory and Immune Changes in Zoster-affected Dermatomes: A Review* Vincenzo RUOCCO, Sonia SANGIULIANO, Giampiero BRUNETTI and Eleonora RUOCCO Department of Dermatology, Second University of Naples, Naples, Italy Neuroepidermal tropism of varicella-zoster virus ac- neuralgia, descends centrifugally through the sensory counts for cutaneous and nerve lesions following herpes nerves, causing intense neuritis, and is released by the zoster. Skin lesions heal in a few weeks and may or may nerve endings in the skin or mucosal surfaces innerva- not leave visible scars. Nerve lesions involve peripheral ted by the affected neural segment, where it replicates sensory fibres, sometimes causing permanent damage producing the characteristic cluster of vesicles (herpes that results in partial denervation of the affected derma- zoster). Importantly, herpes zoster occurs most often in tome. The effects of the nerve injury involve the sensi- dermatomes where the varicella rash is most dense, na- bility function, thus causing neuralgia, itch, allodynia, mely those innervated by the first (ophthalmic) division hypo- or anaesthesia, as well as the immune function that of the trigeminal nerve and by the spinal sensory ganglia is related to neuropeptide release, thus altering immune from T1 to L2 (1). In immunocompromised patients, control in the affected dermatome. The neuro-immune herpes zoster may affect more than one dermatome, destabilization in the zoster-infected site paves the way even if the dermatomes are non-contiguous and bilateral for the onset of many and various immunity-related dis- (herpes zoster duplex), or it may last a long time with no orders along the affected dermatome.
    [Show full text]
  • Handbook on Clinical Neurology and Neurosurgery
    Alekseenko YU.V. HANDBOOK ON CLINICAL NEUROLOGY AND NEUROSURGERY FOR STUDENTS OF MEDICAL FACULTY Vitebsk - 2005 УДК 616.8+616.8-089(042.3/;4) ~ А 47 Алексеенко Ю.В. А47 Пособие по неврологии и нейрохирургии для студентов факуль­ тета подготовки иностранных граждан: пособие / составитель Ю.В. Алексеенко. - Витебск: ВГМ У, 2005,- 495 с. ISBN 985-466-119-9 Учебное пособие по неврологии и нейрохирургии подготовлено в соответствии с типовой учебной программой по неврологии и нейрохирургии для студентов лечебного факультетов медицинских университетов, утвержденной Министерством здравоохра­ нения Республики Беларусь в 1998 году В учебном пособии представлены ключевые разделы общей и частной клиниче­ ской неврологии, а также нейрохирургии, которые имеют большое значение в работе врачей общей медицинской практики и системе неотложной медицинской помощи: за­ болевания периферической нервной системы, нарушения мозгового кровообращения, инфекционно-воспалительные поражения нервной системы, эпилепсия и судорожные синдромы, демиелинизирующие и дегенеративные поражения нервной системы, опу­ холи головного мозга и черепно-мозговые повреждения. Учебное пособие предназначено для студентов медицинского университета и врачей-стажеров, проходящих подготовку по неврологии и нейрохирургии. if' \ * /’ L ^ ' i L " / УДК 616.8+616.8-089(042.3/.4) ББК 56.1я7 б.:: удгритний I ISBN 985-466-119-9 2 CONTENTS Abbreviations 4 Motor System and Movement Disorders 5 Motor Deficit 12 Movement (Extrapyramidal) Disorders 25 Ataxia 36 Sensory System and Disorders of Sensation
    [Show full text]
  • WCN19 Journal Posters Part 1 V1
    JNS-0000116541; No. of Pages 170 ARTICLE IN PRESS Journal of the Neurological Sciences (2019) xxx–xxx Contents lists available at ScienceDirect Journal of the Neurological Sciences journal homepage: www.elsevier.com/locate/jns WCN19 Journal Posters Part 1_V1 WCN19-0018 doi:10.1016/j.jns.2019.10.412 Poster shift 01 - Channelopathies/neuroethics/neurooncology/ pain - Part I/sleep disorders - Part I/stem cells and gene therapy - WCN19-1690 Part I/stroke/training in neurology - Part I and traumatic brain injury Poster shift 01 - Channelopathies/neuroethics/neurooncology/ The paradoxical protective effect of hepatic steatosis on severity pain - Part I/sleep disorders - Part I/stem cells and gene therapy - and functional outcome in patients with first-ever ischaemic Part I/stroke/training in neurology - Part I and traumatic brain stroke or transient ischaemic attack injury M. Baika, S.U. Kimb, H.S. Nama, J.H. Heoa, Y.D. Kima Cerebral distribution of cerebral emboli in patients with patent aYonsei University College of Medicine, Department of Neurology, Seoul, foramen ovale using 99MTC-MAA brain SPECT Republic of Korea b Yonsei University College of Medicine, Department of Internal medi- R. Nematiac, M. Jalalibd, M. Assadibd cine- Yonsei Liver Centre, Seoul, Republic of Korea a2Nuclear Medicine Research Center, Department of Molecular Imaging and Radionuclide Therapy MIRT- Bushehr Medical University Hospital- Background Faculty of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran There is very limited information on the relationship between non- bNuclear Medicine Research Center, Department of Molecular Imaging alcoholic fatty liver disease (NAFLD) and the severity or functional and Radionuclide Therapy MIRT- Bushehr Medical University Hospital- outcomes of ischaemic stroke or transient ischaemic stroke (TIA).
    [Show full text]
  • Paroxysmal Symptoms in Multiple Sclerosis—A Review of the Literature
    Journal of Clinical Medicine Review Paroxysmal Symptoms in Multiple Sclerosis—A Review of the Literature Joumana Freiha 1,2, Naji Riachi 1,2, Moussa A. Chalah 3,4 , Romy Zoghaib 1,2, Samar S. Ayache 3,4 and Rechdi Ahdab 1,2,5,* 1 Gilbert and Rose Mary Chagoury School of Medicine, Lebanese American University, Byblos 4504, Lebanon; [email protected] (J.F.); [email protected] (N.R.); [email protected] (R.Z.) 2 Neurology Department, Lebanese American University Medical Center Rizk Hospital, Beirut 113288, Lebanon 3 Service de Physiologie-Explorations Fonctionnelles, Hôpital Henri Mondor, Assistance Publique–Hôpitaux de Paris, 51 avenue de Lattre de Tassigny, 94010 Créteil, France; [email protected] (M.A.C.); [email protected] (S.S.A.) 4 EA 4391, Excitabilité Nerveuse et Thérapeutique, Université Paris-Est-Créteil, 94010 Créteil, France 5 Hamidy Medical Center, Tripoli 1300, Lebanon * Correspondence: [email protected]; Tel.: +961-1-200800 (ext. 5126) Received: 24 August 2020; Accepted: 19 September 2020; Published: 25 September 2020 Abstract: Paroxysmal symptoms are well-recognized manifestations of multiple sclerosis (MS). These are characterized by multiple, brief, sudden onset, and stereotyped episodes. They manifest as motor, sensory, visual, brainstem, and autonomic symptoms. When occurring in the setting of an established MS, the diagnosis is relatively straightforward. Conversely, the diagnosis is significantly more challenging when they occur as the initial manifestation of MS. The aim of this review is to summarize the various forms of paroxysmal symptoms reported in MS, with emphasis on the clinical features, radiological findings and treatment options.
    [Show full text]
  • Interventions for Iatrogenic Inferior Alveolar and Lingual Nerve Injury (Review)
    Interventions for iatrogenic inferior alveolar and lingual nerve injury (Review) Coulthard P, Kushnerev E, Yates JM, Walsh T, Patel N, Bailey E, Renton TF This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2014, Issue 4 http://www.thecochranelibrary.com Interventions for iatrogenic inferior alveolar and lingual nerve injury (Review) Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 PLAINLANGUAGESUMMARY . 2 SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . ..... 4 BACKGROUND .................................... 6 OBJECTIVES ..................................... 7 METHODS ...................................... 7 Figure1. ..................................... 10 RESULTS....................................... 11 Figure2. ..................................... 12 DISCUSSION ..................................... 14 AUTHORS’CONCLUSIONS . 14 ACKNOWLEDGEMENTS . 15 REFERENCES ..................................... 15 CHARACTERISTICSOFSTUDIES . 17 DATAANDANALYSES. 24 ADDITIONALTABLES. 24 APPENDICES ..................................... 24 HISTORY....................................... 26 CONTRIBUTIONSOFAUTHORS . 27 DECLARATIONSOFINTEREST . 27 SOURCESOFSUPPORT . 27 DIFFERENCES BETWEEN PROTOCOL AND REVIEW . .... 28 Interventions for iatrogenic inferior alveolar and lingual nerve injury (Review) i Copyright © 2014 The Cochrane Collaboration.
    [Show full text]
  • Appendix D: Differential Diagnosis of Epilepsy in Children, Young People and Adults
    Appendix D: Differential diagnosis of epilepsy in children, young people and adults Differential diagnosis of epilepsy in adults CG137 NICE guideline appendix D 1 of 4 • Epilepsy • Syncope with secondary jerking movements • Primary cardiac or respiratory abnormalities, presenting with secondary anoxic seizures • Involuntary movement disorders and other neurological conditions • Hyperekplexia • Non-epileptic attack disorder (NEAD) • Epilepsy • Cardiovascular • Movement disorders • Brainstem, spinal, or lower limb abnormalities • Cataplexy • Generalised convulsive movements • Metabolic disorders • Idiopathic drop attacks • Drop attacks • Vertebrobasilar ischaemia Abnormal movements • Transient focal motor attacks • Focal motor seizures predominate • Tics • Transient cerebral ischaemia • Facial muscle and eye movements • Tonic spasms of multiple sclerosis • Paroxysmal movement disorders • Episodic phenomena in sleep • Partial seizures • Movement disorders • Other neurological disorders • Normal physiological movements • Frontal lobe epilepsy • Other epilepsies • Pathological fragmentary myoclonus • Restless leg syndrome • Non REM/REM parasomnias • Sleep apnoea • Other movements in sleep • Syncope • Epilepsy • Cardiac disorders • Microsleeps • Panic attacks • Hypoglycaemia • Other neurological disorders • Non-epileptic attack disorder (NEAD) • Loss of awareness • Somatosensory attacks: epileptic seizure, transient ischaemic attack, hyperventilation Disturbed • Transient vestibular symptoms: peripheral vestibular disease, epilepsy • Visual
    [Show full text]
  • CNS 2018 Abstract Book
    Behavioural and electrophysiological measurements of lapses in sustained auditory attention Poster A1, Saturday, March 24, 1:30–3:30 pm, Exhibit Hall C Alice E Milne1, Daniel I R Bates1, Maria Chait1; 1UCL, London Top-down attention during noisy auditory scenes boosts perception of task-relevant stimuli, while inhibiting irrelevant signals. However, sustaining attention over extended periods of time is challenging and leads to lapses in attention. Recordings from macaque auditory cortex show that neural alpha-oscillations and entrainment reflect transient changes in attentional state. However, it is unknown how the human neural response to auditory stimuli is affected by attentional lapses. We designed a novel paradigm to study unintentional breaks in sustained attention. Participants were required to track pitch changes in a pure-tone pulse stream. To increase perceptual load, the target stream was flanked by two additional pulse-streams of different pitch and pulse rates, along with attention-capturing high-pitch tone pips and a flickering visual Gabor-patch. Trials were 5-mins long with behavioural responses captured semi-continuously (2-7 seconds). Critically, control trials presented the same auditory and visual stimuli but participants performed a low-attention task, responding to the salient tone pips or Gabor orientation changes. Variations in false alarms, misses and reaction times were used to identify periods when attention to the target stream lapsed. EEG data was acquired using the same paradigm and the behavioural data used to determine the occurrence of attentional lapses. These time periods were then used to characterise the dynamic neural changes that result from variations in attentional states, specifically for alpha-band activity and neural entrainment.
    [Show full text]
  • Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death
    INTERNATIONAL CLASSIFICATION OF DISEASES MANUAL OF THE INTERNATIONAL STATISTICAL CLASSIFICATION OF DISEASES, INJURIES, AND CAUSES OF DEATH Based on the Recommendations of the Ninth Revision Conference, 1975, and Adopted by the Twenty-ninth Wodd Health Assembly Volume 1 WORLD HEALTH• ORGANIZATION GENEVA 1977 Reprinted 1974, 1980, 1986 Volume 1 Introduction List of Three-digit Categories Tabular List of Inclusions and Four-digit Sub- categories Medical Certification and Rules for Classification Special Lists for Tabulation Definitions and Recommendations Regulations Volume 2 Alphabetical Index ISBN 92 4 154004 4 © World Health Organization 1977 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. For rights of reproduction or translation of WHO publications, in part or in toto, application should be made to the Office of Publications, World Health Organization, Geneva, Switzerland. The World Health Organization welcomes such applications. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its fronti.:rs or boundaries. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. PRINTED IN SWITZERLAND 86/6847 - Presses Centrales - 7000 (R) TABLE OF CONTENTS Page Introduction General Principles VII Historical Review .
    [Show full text]
  • Minamata Disease Revisited: an Update on the Acute and Chronic
    Journal of the Neurological Sciences 262 (2007) 131–144 www.elsevier.com/locate/jns Minamata disease revisited: An update on the acute and chronic manifestations of methyl mercury poisoning ⁎ Shigeo Ekino a, , Mari Susa b, Tadashi Ninomiya a, Keiko Imamura a, Toshinori Kitamura c a Department of Histology, Graduate School of Medical Sciences, Kumamoto University, Honjo, 860-8556 Kumamoto, Japan b Faculty of Law, Kumamoto University, Kurokami, 860-8555 Kumamoto, Japan c Department of Psychological Medicine, Graduate School of Medical Sciences, Kumamoto University, Honjo, 860-8556 Kumamoto, Japan Available online 2 August 2007 Abstract The first well-documented outbreak of acute methyl mercury (MeHg) poisoning by consumption of contaminated fish occurred in Minamata, Japan, in 1953. The clinical picture was officially recognized and called Minamata disease (MD) in 1956. However, 50 years later there are still arguments about the definition of MD in terms of clinical symptoms and extent of lesions. We provide a historical review of this epidemic and an update of the problem of MeHg toxicity. Since MeHg dispersed from Minamata to the Shiranui Sea, residents living around the sea were exposed to low-dose MeHg through fish consumption for about 20 years (at least from 1950 to 1968). These patients with chronic MeHg poisoning continue to complain of distal paresthesias of the extremities and the lips even 30 years after cessation of exposure to MeHg. Based on findings in these patients the symptoms and lesions in MeHg poisoning are reappraised. The persisting somatosensory disorders after discontinuation of exposure to MeHg were induced by diffuse damage to the somatosensory cortex, but not by damage to the peripheral nervous system, as previously believed.
    [Show full text]
  • Name; Jacksonabara Emmanuella Odegwa Department;Nursing Matric No; 18/MHS07/027 Course Code;PHS 212 Assignment;Discuss the Somatosensory Pathways
    Name; JacksonAbara Emmanuella Odegwa Department;Nursing Matric No; 18/MHS07/027 Course code;PHS 212 Assignment;Discuss the somatosensory pathways The somatosensory system is a part of the sensory nervous system. The somatosensory system is a complex system of sensory neurons and neural pathways that responds to changes at the surface or inside the body.The somatosensory system is distributed throughout all major parts of our body. It is responsible for sensing touch, temperature, posture, limb position, and more. It includes both sensory receptor neurons in the periphery (eg., skin, muscle, and organs) and deeper neurons within the central nervous system. The somatosensory system is spread through all major parts of the vertebrate body. It consists both of sensory receptors and afferent neurons in the periphery (skin, muscle and organs for example), to deeper neurons within the central nervous system. Somatic senses are sometimes referred to as somesthetic senses, with the understanding that somesthesis includes the sense of touch, proprioception (sense of position and movement), and (depending on usage) haptic perception. Structure A somatosensory pathway will typically consist of three neurons: primary, secondary, and tertiary. Ø In the periphery, the primary neuron is the sensory receptor that detects sensory stimuli like touch or temperature. Ø The secondary neuron acts as a relay and is located in either the spinal cord or the brainstem. Ø Tertiary neurons have cell bodies in the thalamus and project to the postcentral gyrus of the parietal lobe, forming a sensory homunculus in the case of touch. Functions The somatosensory system functions in the body’s periphery, spinal cord, and the brain.
    [Show full text]